Johnson & Johnson Joins Forces With Veracyte For Lung Cancer Diagnostics
Executive Summary
Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.
You may also be interested in...
Veracyte, J&J Launch NOBLE Trial For Lung Cancer Detection
The 9,000-patient clinical study will identify genomic and other differences in lung cancer development and progression among patients with lung nodules detected by computed tomography.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: